QurieGen at Swiss Biotech Day 2026: Partnering in Drug Discovery, Biotech Collaboration, and Investment
QurieGen will be at Swiss Biotech Day 2026 on May 4-5 in Basel- one of the most dynamic global biotech gatherings, bringing together the international ecosystem for partnering, networking, and innovation.
Representing QurieGen will be Dr Martina Lutterova, Senior BD Director, ready to connect with pharma and biotech companies, researchers, and investors.
At QurieGen, we’re building AI Virtual Cell models powered by proprietary same-cell multi-omics with temporal resolution, enriched with public and partner data, and continuously improved through a lab-in-the-loop approach.
In short: we aim to bring real biological insight into drug R&D, reducing guesswork and enabling better decisions.
For us, Swiss Biotech Day is not just another event- it’s a chance to:
- Partner with pharma and biotech innovators to improve R&D outcomes
- Build meaningful research collaborations with strong scientific depth
- Connect with investors as we finalize our Seed round syndicate
With over 3,000 participants from 49 countries, Swiss Biotech Day has become a true global hub, and its Global Village is designed to spark exactly the kind of collaborations we care about- across borders, disciplines, and sectors.
If you’ll be there and want to talk AI-driven drug discovery, partnerships, or investment opportunities, reach out to Martina via the event platform, LinkedIn, or the QurieGen website.
Let’s connect and build what’s next 🔥